Evaluation of Glial Cell Line-Derived Neurotrophic Factors as Therapeutics: Pharmacogenomic and Pharmacoproteomic Studies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|11|1|76-85

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.11, Iss.1, 2013-03, pp. : 76-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres

By Agbay Andrew   Mohtaram Nima   Willerth Stephanie  

Drug Delivery and Translational Research, Vol. 4, Iss. 2, 2014-04 ,pp. : 159-170

Springer Publishing Company

Access to resources Recommend Favorite

Ultrastructural Study of Anterograde Transport of Glial Cell Line-Derived Neurotrophic Factor from Dorsal Root Ganglion Neurons of Rats towards the Nerve Terminal

By  

Cells Tissues Organs, Vol. 169, Iss. 4, 2001-07 ,pp. : 410-421

Karger

Access to resources Recommend Favorite

Glial-cell-line-derived neurotrophic factor: gene promoter and receptors

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 779-783

Informa Healthcare

Access to resources Recommend Favorite

The Relationship between Overexpression of Glial Cell-derived Neurotrophic Factor and Its RET Receptor with Progression and Prognosis of Human Pancreatic Cancer

By Zeng Q   Cheng Y   Zhu Q   Yu Z   Wu X   Huang K   Zhou M   Han S   Zhang Q  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 656-664

Field House Publishing

Access to resources Recommend Favorite

Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 13, Iss. 1, 2015-12 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite